Grown Rogue International (GRIN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
22 Apr, 2026Executive summary
Achieved positive cash flow from operations despite a $2M+ EBITDA headwind from lower average selling prices year-over-year.
Pro forma revenue for Q2 2025 was $8.01M, up 4% year-over-year; pro forma adjusted EBITDA was $1.82M, down 12% year-over-year, reflecting margin pressure from pricing declines and growth investments.
Maintained profitability and operational resilience through cost controls and yield improvements.
Expansion efforts continue in New Jersey, Illinois, and Minnesota, with new licenses and facility construction underway.
Focused on long-term growth, not dependent on federal reform, and leveraging low-cost production as a competitive advantage.
Financial highlights
Production costs in Michigan dropped below $400/lbs, Oregon in the mid $400s, with indoor costs estimated sub-$200/lbs.
Oregon revenue: $3.08M (down 16% YoY), adjusted EBITDA: $0.80M (26.1% margin); Michigan revenue: $2.28M (down 34% YoY), adjusted EBITDA: $0.78M (34.2% margin); New Jersey affiliate revenue: $2.65M, adjusted EBITDA: $1.29M (48.6% margin).
Total flower harvested increased 20% in Oregon and 14% in Michigan year-over-year.
Cost per pound produced fell 16% in Oregon and 15% in Michigan year-over-year.
Adjusted EBITDA remained strong despite a significant pricing decline in core markets.
Outlook and guidance
Expecting continued recovery in Oregon and Michigan pricing after recent troughs.
New Jersey phase II construction to complete by early Q2 2026, targeting 1,200 lbs/month capacity.
Anticipate capital-efficient growth from distressed industry opportunities over the next 12-18 months.
Management expects continued pricing pressure but sees opportunity in distressed industry conditions.
No material near-term impact expected from potential federal rescheduling of cannabis.
Latest events from Grown Rogue International
- 2025 revenue rose 22% to $32.4M, with strong growth and expansion set for 2026.GRIN
Q4 20257 Apr 2026 - Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025